Alvotech announces FDA acceptance of Biologics License Application for AVT16, a proposed interchangeable biosimilar to Entyvio
REYKJAVIK, Iceland, June 8, 2026 - Alvotech (NASDAQ: ALVO; ALVO-SDB), a global…
Novartis to highlight Rhapsido data across multiple immune-mediated diseases at EAACI Congress 2026
Results from Rhapsido (remibrutinib) pivotal Phase III RemIND trial, the largest study…
Bavarian Nordic Transactions in Connection with Share Buy-Back Program
COPENHAGEN, Denmark, June 8, 2026 – Bavarian Nordic A/S (OMX: BAVA) announces…
Astrall Dynamics Makes INTERSCHUTZ 2026 Debut with Hypertron-T01 Quadruped Firefighting Robot
HANOVER, Germany, June 07, 2026 (GLOBE NEWSWIRE) -- Astrall Dynamics demonstrated its…
Astrall Dynamics Showcases Unmanned Quadruped Firefighting Robot at INTERSCHUTZ 2026
HANOVER, Germany, June 07, 2026 (GLOBE NEWSWIRE) -- Astrall Dynamics at INTERSCHUTZ…
Astrall Dynamics Unveils Integrated Quadruped Firefighting Robot Hypertron-T01 at INTERSCHUTZ 2026
HANOVER, Germany, June 07, 2026 (GLOBE NEWSWIRE) -- Astrall Dynamics unveiled the…
Real-World Evidence of Eversense 365 Presented at ADA Demonstrating Strong Performance and Patient Impact in Both Open and Closed Loop Systems
Eversense 365 delivered favorable glucometrics compared to other open and closed loop…
Vireo Growth Inc. Completes Acquisition of Bridgewell Agribusiness LLC and Plans to Acquire Dispensaries in Nevada and Maryland
MINNEAPOLIS, June 05, 2026 (GLOBE NEWSWIRE) -- Vireo Growth Inc. (CSE: VREO)…
Premier Health of America Announces Grant of Management Cease Trade Order
MONTREAL, June 05, 2026 (GLOBE NEWSWIRE) -- PREMIER HEALTH OF AMERICA INC.…
Biomea Fusion Presents New Clinical and Translational Data for Icovamenib at the American Diabetes Association (ADA) 86th Scientific Sessions and Announces Expansion of Ongoing Phase I BMF-650 Study
•Translational data presented at ADA demonstrate icovamenib’s potential to promote muscle preservation…
